OKYO Pharma Limited Announces Withdrawal of Public Offering
31. Juli 2023 02:18 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to...